Proactive signal detection and risk management strengthen drug safety programs before issues escalate. Viltis applies structured methodologies to identify, validate, and manage safety signals across clinical and post-market data.
Our experts support risk minimization measures and benefit-risk assessments aligned with regulatory expectations.